134 related articles for article (PubMed ID: 30851152)
1. Primary cutaneous diffuse large B-cell lymphoma, NOS and leg type: Clinical, morphologic and prognostic differences.
Felcht M; Klemke CD; Nicolay JP; Weiss C; Assaf C; Wobser M; Schlaak M; Hillen U; Moritz R; Tantcheva-Poor I; Nashan D; Beyer M; Dippel E; Müller CSL; Sachse MM; Meiss F; Géraud C; Marx A; Goerdt S; Geissinger E; Kempf W
J Dtsch Dermatol Ges; 2019 Mar; 17(3):275-285. PubMed ID: 30851152
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity.
Paulli M; Viglio A; Vivenza D; Capello D; Rossi D; Riboni R; Lucioni M; Incardona P; Boveri E; Bellosta M; Orlandi E; Borroni G; Lazzarino M; Berti E; Alessi E; Magrini U; Gaidano G
Hum Pathol; 2002 Sep; 33(9):937-43. PubMed ID: 12378521
[TBL] [Abstract][Full Text] [Related]
3. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related.
Geelen FA; Vermeer MH; Meijer CJ; Van der Putte SC; Kerkhof E; Kluin PM; Willemze R
J Clin Oncol; 1998 Jun; 16(6):2080-5. PubMed ID: 9626207
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
[TBL] [Abstract][Full Text] [Related]
5. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases.
Plaza JA; Kacerovska D; Stockman DL; Buonaccorsi JN; Baillargeon P; Suster S; Kazakov DV
Am J Dermatopathol; 2011 Oct; 33(7):649-55; quiz 656-8. PubMed ID: 21937906
[TBL] [Abstract][Full Text] [Related]
6. Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study.
Sundram U; Kim Y; Mraz-Gernhard S; Hoppe R; Natkunam Y; Kohler S
J Cutan Pathol; 2005 Mar; 32(3):227-34. PubMed ID: 15701085
[TBL] [Abstract][Full Text] [Related]
7. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.
Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD
Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270
[TBL] [Abstract][Full Text] [Related]
8. Bone involvement in two cases of thoracic primary cutaneous diffuse large B-cell lymphoma, leg type.
Lipowicz S; Beylot-Barry M; Choquet S; Maksud P; Vergier B; Albertini AF; Frances C; Barete S
Eur J Dermatol; 2011; 21(5):744-9. PubMed ID: 21700538
[TBL] [Abstract][Full Text] [Related]
9. [Primary cutaneous diffuse large B-cell lymphoma, leg type: a study of clinicopathology, immunophenotype and gene rearrangement].
Wang T; Jia L; Liao W; Chen L; Chen X; Xiong Y; Hao F; Zhu X; Yang X; Wang L
Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):100-5. PubMed ID: 25916640
[TBL] [Abstract][Full Text] [Related]
10. FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type.
Espinet B; García-Herrera A; Gallardo F; Baró C; Salgado R; Servitje O; Estrach T; Colomo L; Romagosa V; Barranco C; Serrano S; Campo E; Pujol RM; Solé F
Histol Histopathol; 2011 Feb; 26(2):213-21. PubMed ID: 21154235
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
[TBL] [Abstract][Full Text] [Related]
13. High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type.
Pham-Ledard A; Beylot-Barry M; Barbe C; Leduc M; Petrella T; Vergier B; Martinez F; Cappellen D; Merlio JP; Grange F
JAMA Dermatol; 2014 Nov; 150(11):1173-9. PubMed ID: 25055137
[TBL] [Abstract][Full Text] [Related]
14. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Schrader AMR; Jansen PM; Vermeer MH; Kleiverda JK; Vermaat JSP; Willemze R
Am J Surg Pathol; 2018 Nov; 42(11):1488-1494. PubMed ID: 30113335
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.
Grange F; Bekkenk MW; Wechsler J; Meijer CJ; Cerroni L; Bernengo M; Bosq J; Hedelin G; Fink Puches R; van Vloten WA; Joly P; Bagot M; Willemze R
J Clin Oncol; 2001 Aug; 19(16):3602-10. PubMed ID: 11504742
[TBL] [Abstract][Full Text] [Related]
16. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes.
Goodlad JR; Krajewski AS; Batstone PJ; McKay P; White JM; Benton EC; Kavanagh GM; Lucraft HH;
Am J Surg Pathol; 2003 Dec; 27(12):1538-45. PubMed ID: 14657713
[TBL] [Abstract][Full Text] [Related]
18. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma.
Dijkman R; Tensen CP; Jordanova ES; Knijnenburg J; Hoefnagel JJ; Mulder AA; Rosenberg C; Raap AK; Willemze R; Szuhai K; Vermeer MH
J Clin Oncol; 2006 Jan; 24(2):296-305. PubMed ID: 16330669
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the B-Cell Receptor Pathway Confer Chemoresistance in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.
Ducharme O; Beylot-Barry M; Pham-Ledard A; Bohers E; Viailly PJ; Bandres T; Faur N; Frison E; Vergier B; Jardin F; Merlio JP; Gros A
J Invest Dermatol; 2019 Nov; 139(11):2334-2342.e8. PubMed ID: 31150604
[TBL] [Abstract][Full Text] [Related]
20. Atypical clinicopathologic presentation of primary cutaneous diffuse large B-cell lymphoma, leg type.
Massone C; Fink-Puches R; Wolf I; Zalaudek I; Cerroni L
J Am Acad Dermatol; 2015 Jun; 72(6):1016-20. PubMed ID: 25824272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]